Related Experiment Video
Updated: Aug 18, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
[Abnormality of p15(INK4b) gene and myelodysplastic syndrome]
1Institute of Hematology, Medical College of Jinan University, Guangzhou 510632, China.
Abstract:
Among tumor suppressor genes, p15(INK4b) gene is gaining more attention for its important role in the progression of myelodyplastic syndrome (MDS). Serial studies demonstrated that highly frequent hypermethylation of p15(INK4b) gene, which is located at the 5'CpG island in the promoter region of exon 1 and is the main reason of inactivation of p15(INK4b) gene, occurs during the development of MDS towards AML. The assay of methylation-specific PCR (MSP) is sensitive to this pattern of methylation which is restricted to the MDS clone. Apoptosis mediated by cytokines such as Fas antigen and TGF-beta, and bHLH proteins is inhibited by the inactivation of p15(INK4b) gene. This may result in the evolution of MDS clone to AML. In as much as the close relationship between p15(INK4b) gene methylation and MDS, modulation of the methylation status of p15(INK4b) gene may be considered as a noval treatment modality for MDS.
Insights
Hypermethylation of the p15(INK4b) gene is a key driver in myelodysplastic syndrome (MDS) progression to acute myeloid leukemia (AML). Targeting this gene methylation offers a potential novel therapeutic strategy for MDS.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Context:
- The p15(INK4b) gene, a crucial tumor suppressor, plays a significant role in myelodysplastic syndrome (MDS) pathogenesis.
- Frequent hypermethylation of the p15(INK4b) gene promoter region is observed during MDS progression to acute myeloid leukemia (AML).
Purpose:
- To investigate the role of p15(INK4b) gene hypermethylation in MDS development and progression.
- To explore the potential of modulating p15(INK4b) methylation as a therapeutic approach for MDS.
Summary:
- Hypermethylation of the p15(INK4b) gene promoter, detected by methylation-specific PCR (MSP), is a frequent event in MDS and is associated with MDS clone evolution.
- Inactivation of p15(INK4b) inhibits apoptosis, potentially facilitating the transition from MDS to AML.
- The methylation status of p15(INK4b) is closely linked to MDS, suggesting its modulation as a novel treatment strategy.
Impact:
- Understanding the epigenetic regulation of p15(INK4b) in MDS provides insights into leukemogenesis.
- Targeting p15(INK4b) methylation may offer a new therapeutic avenue for MDS patients, potentially preventing AML transformation.
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...

